Serum IL-8 may have clinical utility as a biomarker for WMH in AD. Longitudinal follow-up studies would help validate these findings.
Authors: Yanan Zhu, Yuek Ling Chai, Saima Hilal, M. Kamran Ikram, Narayanaswamy Venketasubramanian, Boon‐Seng Wong, Christopher Chen, Mitchell K.P. Lai
DOI: https://doi.org/10.1016/j.dadm.2017.01.001
Publish Year: 2017
